Pfizer (MEX:PFE) Cash Flow for Dividends: MXN-178,985 Mil (TTM As of Mar. 2026)


MEX:PFE Pfizer Inc MEX:PFE
67 GF Score
Price MXN413.87
GF Value MXN455.66
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Pfizer Cash Flow for Dividends?

Pfizer MEX:PFE -2.84% 67 Cash Flow for Dividends is MXN-178,985 Mil as of Mar. 2026. GuruFocus rates MEX:PFE with a GF Score™ of 67/100 and a GF Value™ of MXN455.66 (Fairly Valued). The stock has 5 warning signs investors should review.

Pfizer's cash flow for dividends for the three months ended in Mar. 2026 was MXN-44,090 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was MXN-178,985 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Pfizer's quarterly payment of dividends declined from Sep. 2025 (MXN-44,833 Mil) to Dec. 2025 (MXN-44,024 Mil) but then increased from Dec. 2025 (MXN-44,024 Mil) to Mar. 2026 (MXN-44,090 Mil).

Pfizer's annual payment of dividends increased from Dec. 2023 (MXN-156,961 Mil) to Dec. 2024 (MXN-198,379 Mil) but then declined from Dec. 2024 (MXN-198,379 Mil) to Dec. 2025 (MXN-175,934 Mil).

Pfizer Cash Flow for Dividends Related Terms

Pfizer Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Pfizer's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pfizer Cash Flow for Dividends Chart

Pfizer Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -179,066.71 -175,132.57 -156,960.87 -198,379.42 -175,933.70

Pfizer Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -49,856.63 -46,037.39 -44,833.23 -44,023.94 -44,089.95
MEX:PFE
67GF Score
Pfizer Inc MEX:PFE
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pfizer Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-178,985 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of MXN-178,985 Mil mean?
Pfizer (MEX:PFE) has a Cash Flow for Dividends of MXN-178,985 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Pfizer and its competitors.
Is Pfizer's Cash Flow for Dividends too high?
Pfizer's current Cash Flow for Dividends is MXN-178,985 Mil. Overall, Pfizer has a GF Score™ of 67/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pfizer's Cash Flow for Dividends compare to GILD and BMY?
Pfizer's Cash Flow for Dividends of MXN-178,985 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Pfizer and its competitors. Pfizer's current Cash Flow for Dividends is MXN-178,985 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pfizer stock overvalued right now?
Based on GuruFocus' analysis, Pfizer (MEX:PFE) is currently considered Fairly Valued. The stock's GF Value™ is MXN455.66, compared to a current price of MXN413.87 — trading 9.2% below its estimated fair value. The current Cash Flow for Dividends is MXN-178,985 Mil. Pfizer's overall GF Score™ is 67/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Pfizer (MEX:PFE), the current Cash Flow for Dividends is MXN-178,985 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pfizer (MEX:PFE) Overvalued in 2026?

Based on GuruFocus' analysis, Pfizer stock appears to be undervalued. The current stock price of MXN413.87 is trading 9.2% below its estimated GF Value™ of MXN455.66. GuruFocus considers Pfizer to be Fairly Valued.

Key valuation signals for MEX:PFE:

  • Cash Flow for Dividends: MXN-178,985 Mil
  • GF Value™: MXN455.66 vs. price of MXN413.87 (9.2% below fair value)
  • GF Score™: 67/100 with 5 warning signs

No single metric tells the full story. See the MEX:PFE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pfizer Business Description

Address 66 Hudson Boulevard East, New York, NY, USA, 10001-2192
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
67GF Score

Get the complete analysis for MEX:PFE

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN413.87
Price
MXN455.66
GF Value